• Lazard, Inc. recently appointed Bill Young as Head of Diversified Industrials alongside Jean Greene and Paolo Battaglia as Managing Directors in the firm’s Global Industrials Group, all joining the New York office.
• This move brings together proven leadership from large investment banks and seasoned institutional expertise, reinforcing Lazard’s industrials advisory capabilities across key sectors such as aerospace and defense, building products, and chemicals.
• We’ll now explore how bringing on industry veterans to its Global Industrials Group influences Lazard’s overall investment narrative and growth outlook.

The latest GPUs need a type of rare earth metal called Terbium and there are only 36 companies in the world exploring or producing it. Find the list for free.

Lazard Investment Narrative Recap

To be a shareholder in Lazard, you need to believe in the company’s ability to grow through expanding its advisory talent and capturing opportunities across diversified global sectors. The recent appointments of Bill Young, Jean Greene, and Paolo Battaglia add sector experience to the Industrials Group, but are unlikely to materially impact the near-term catalyst of margin pressure from expansion, or address the main risk of higher operating costs outpacing revenue gains in new markets.

The firm's earlier announcement of opening a new financial advisory office in Abu Dhabi stands out as especially relevant, as it highlights Lazard's continued push into new regions. This aligns directly with current growth catalysts but underscores ongoing risks from higher near-term expenses before new revenues materialize.

In contrast, investors should stay mindful of how ongoing geographic expansion could increase operating costs faster than revenues, particularly if...

Lazard's narrative projects $4.2 billion revenue and $620.0 million earnings by 2028. This requires 11.3% yearly revenue growth and a $317.5 million increase in earnings from $302.5 million today.

Uncover how Lazard's forecasts yield a $58.17 fair value, a 15% upside to its current price.

Exploring Other Perspectives

Four Simply Wall St Community members estimate Lazard’s fair value spans from US$47 to US$75.15. Expanding into new markets is a current catalyst, but you will find wide differences of opinion, explore the full range of community views.

Explore 4 other fair value estimates on Lazard - why the stock might be worth 7% less than the current price!

Build Your Own Lazard Narrative

Disagree with existing narratives? Create your own in under 3 minutes - extraordinary investment returns rarely come from following the herd.

• A great starting point for your Lazard research is our analysis highlighting 3 key rewards and 3 important warning signs that could impact your investment decision.
• Our free Lazard research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Lazard's overall financial health at a glance.

Looking For Alternative Opportunities?

Our daily scans reveal stocks with breakout potential. Don't miss this chance:

• Outshine the giants: these 25 early-stage AI stocks could fund your retirement.
• Find companies with promising cash flow potential yet trading below their fair value.
• The end of cancer? These 29 emerging AI stocks are developing tech that will allow early identification of life changing diseases like cancer and Alzheimer's.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.